Pursuant to Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Gland Pharma has informed that it enclosed the schedule of the Analyst/ Institutional Investor Meeting with the Company to be held on 24 th November, 2023.
The above information is a part of company’s filings submitted to BSE.